Iterum Therapeutics Debt 2024

Iterum Therapeutics Aktienanalyse

What does Iterum Therapeutics do?

Iterum Therapeutics is an Irish biotechnology company that focuses on developing antibiotics for serious bacterial infections. The company was founded in 2015 and has since undergone several successful financing rounds. The business model of Iterum Therapeutics is based on the discovery, development, and commercialization of novel anti-infectives that specialize in hard-to-reach or resistant bacteria. The company has developed a strong pipeline of antibiotic products that aim to combat the growing threat of antibiotic resistance. Iterum Therapeutics operates in several sectors, including clinical development, manufacturing, and marketing of antibiotic products. The company collaborates with leading industry players to ensure the effectiveness and safety of its products. One of Iterum Therapeutics' products is Sulopenem, a novel antibiotic specifically developed for treating infections caused by various types of bacteria. Sulopenem has shown promise in clinical studies and has the potential to play a significant role in combating antibiotic resistance. In addition, Iterum Therapeutics is also developing other antibiotic products focusing on combating bacteria responsible for severe infections, including Pseudomonas aeruginosa and Enterobacteriaceae. Iterum Therapeutics has a strong research and development department that focuses on the discovery and development of new antibiotic products. The company works closely with leading universities and research institutions to build a strong pipeline of innovative anti-infectives. The products of Iterum Therapeutics have the potential to make a significant contribution to combating antibiotic resistance and serious infections. The company is committed to further advancing the growth of its pipeline and maximizing the potential of its products to improve the health of patients worldwide. Iterum Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Iterum Therapeutics's Debt Structure

Iterum Therapeutics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Iterum Therapeutics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Iterum Therapeutics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Iterum Therapeutics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Iterum Therapeutics Stock

What is the debt of Iterum Therapeutics this year?

Iterum Therapeutics has a debt level of 12.88 USD this year.

What was the debt of Iterum Therapeutics compared to the previous year?

The debt of Iterum Therapeutics has increased by 74.59% compared to the previous year increased.

What are the consequences of high debt for investors in Iterum Therapeutics?

High debt can pose a risk for investors of Iterum Therapeutics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Iterum Therapeutics?

Low debt means that Iterum Therapeutics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Iterum Therapeutics affect the company?

An increase in debt of Iterum Therapeutics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Iterum Therapeutics affect the company?

A reduction in debt of Iterum Therapeutics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Iterum Therapeutics?

Some factors that can influence the debt of Iterum Therapeutics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Iterum Therapeutics so important for investors?

The debts of Iterum Therapeutics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Iterum Therapeutics take to change the debt?

To change the debt, Iterum Therapeutics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Iterum Therapeutics pay?

Over the past 12 months, Iterum Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Iterum Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Iterum Therapeutics?

The current dividend yield of Iterum Therapeutics is .

When does Iterum Therapeutics pay dividends?

Iterum Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Iterum Therapeutics?

Iterum Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Iterum Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Iterum Therapeutics located?

Iterum Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Iterum Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Iterum Therapeutics from 6/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/13/2024.

When did Iterum Therapeutics pay the last dividend?

The last dividend was paid out on 6/13/2024.

What was the dividend of Iterum Therapeutics in the year 2023?

In the year 2023, Iterum Therapeutics distributed 0 USD as dividends.

In which currency does Iterum Therapeutics pay out the dividend?

The dividends of Iterum Therapeutics are distributed in USD.